Trattamento sequenziale con everolimus e sunitinib in tumori neuroendocrini pancreatici, ben differenziati, metastatici, resistenti alle precedenti terapie
Crossref DOI link: https://doi.org/10.1007/s40619-018-00504-x
Published Online: 2018-12-06
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Di Maio, Silvana
Faggiano, Antongiulio
Text and Data Mining valid from 2018-12-01
Article History
First Online: 6 December 2018